Fulcrum Therapeutics (FULC) Revenue & Revenue Breakdown
Fulcrum Therapeutics Revenue Highlights
Latest Revenue (Y)
$2.81M
Fulcrum Therapeutics Revenue by Period
Fulcrum Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $2.81M | -55.77% |
| 2022-12-31 | $6.34M | -66.90% |
| 2021-12-31 | $19.16M | 117.19% |
| 2020-12-31 | $8.82M | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2017-12-31 | - | - |
Fulcrum Therapeutics generated $2.81M in revenue during NA 2023, up -55.77% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Fulcrum Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-09-30 | - | -100.00% |
| 2024-06-30 | $80.00M | 100.00% |
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $871.00K | 14.76% |
| 2023-09-30 | $759.00K | -13.75% |
| 2023-06-30 | $880.00K | 198.31% |
| 2023-03-31 | $295.00K | -56.93% |
| 2022-12-31 | $685.00K | -42.10% |
| 2022-09-30 | $1.18M | -37.14% |
| 2022-06-30 | $1.88M | -27.39% |
| 2022-03-31 | $2.59M | -48.75% |
| 2021-12-31 | $5.06M | 2.49% |
| 2021-09-30 | $4.93M | 12.65% |
| 2021-06-30 | $4.38M | -8.52% |
| 2021-03-31 | $4.79M | 13.35% |
| 2020-12-31 | $4.22M | 128.63% |
| 2020-09-30 | $1.85M | -7.60% |
| 2020-06-30 | $2.00M | 166.67% |
| 2020-03-31 | $750.00K | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | - |
Fulcrum Therapeutics generated - in revenue during Q2 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.